NCT05569031View on ClinicalTrials.gov

Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 15, 2021

Study Completion Date

June 15, 2022

Conditions
Opiate Withdrawal Syndrome
Interventions
DRUG

Venlafaxine

patients with tramadol abuse will use venlafaxine for 10 days.

DRUG

Lofexidine

patients with tramadol abuse will use lofixidine for 10 days.

Trial Locations (1)

44519

Faculty of medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05569031 - Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse | Biotech Hunter | Biotech Hunter